ArticleBMJ open2021

Vasohibin-1 expression as a biomarker of aggressive nature in ductal adenocarcinoma of the prostate: a retrospective cohort study at two centres in Japan.

Hiroaki Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.